Two Benefits, One Patient

Drug spending does not arrive in one place. It arrives through two separate payment channels with different rules, different intermediaries, and different visibility, and almost every confusion in this area traces to that split.

The two channels

The pharmacy benefit covers drugs a patient picks up or receives by mail. Claims run through a pharmacy benefit manager in real time at the point of sale, the patient pays a copay or coinsurance defined by a formulary tier, and the plan reconciles rebates with manufacturers afterward.

The medical benefit covers drugs a clinician administers: infusions, injections given in an office or hospital outpatient department, and anything delivered as part of a procedure. These are billed on medical claims. Under the classic buy-and-bill arrangement, the provider purchases the drug, administers it, and bills the payer, so the provider’s margin is the difference between acquisition cost and reimbursement.

	Pharmacy benefit	Medical benefit
Who dispenses	Retail, mail, or specialty pharmacy	Clinician in an office, clinic, or hospital
Claim type	Pharmacy claim, adjudicated at point of sale	Medical claim, submitted after the fact
Managed by	Pharmacy benefit manager, formulary and tiers	Medical policy, prior authorization, site of care
In Medicare	Part D	Part B
Visibility to an accountable provider organization	Often poor	Better, since it is in medical claims

Why this split matters so much

Three consequences follow directly.

The same drug can move between channels. An infused therapy administered in a hospital outpatient department is medical benefit spending; a self-administered alternative is pharmacy benefit spending. Site of care management, covered in Module 4, exploits exactly this.

Management tools differ. A formulary controls the pharmacy benefit. Prior authorization and site-of-care policy control the medical benefit. An organization that has optimized one has done nothing about the other.

Visibility differs. The data course explained that an organization can only manage what it can see. Medical benefit drug spending sits in claims an accountable organization usually receives. Pharmacy benefit spending frequently does not, especially where the pharmacy benefit is administered separately.

Worth remembering: the medical and pharmacy split is the drug-spend version of the behavioral health carve-out. In both cases an administrative boundary determines who sees the spending, who can manage it, and who benefits from improving it, and in both cases the patient experiences one continuous course of treatment. When someone says their organization manages drug spend, the useful question is which benefit they mean, because the answer is almost never both.

Key takeaways

• Drugs dispensed by pharmacies flow through the pharmacy benefit; drugs administered by clinicians flow through the medical benefit.
• In Medicare these correspond to Part D and Part B respectively.
• The same therapy can shift between benefits depending on setting, which is the basis of site-of-care strategies.
• Formularies manage one channel and prior authorization and site policy manage the other, so optimizing one changes nothing about the other.

Sources

• KFF, A Current Snapshot of the Medicare Part D Prescription Drug Benefit (opens in a new tab)
• CMS, 2026 Medicare Parts A and B Premiums and Deductibles (opens in a new tab)